Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Mexico infusion therapy market was valued at USD 2.42 Billion in 2025 and is expected to grow at a CAGR of 6.10%, reaching USD 4.37 Billion by 2035. The market growth is driven by expanding healthcare infrastructure, strengthened safety standards, and faster regulatory approvals that support wider adoption of advanced infusion therapies across the region.
Base Year
Historical Period
Forecast Period
Growing investment in Mexico’s healthcare system is expected to strengthen infusion services, with hospitals adopting safer technologies and expanding access through modern units supported by clinical infusion devices across the country.
Rising cases of chronic illnesses are likely to accelerate demand for precise infusion treatments, pushing providers to upgrade equipment and integrate smarter solutions driven by advanced IV therapy innovation.
Regulatory reforms that fast-track medical device approvals are set to attract more global manufacturers, enhancing product availability and boosting the adoption of high-quality infusion delivery systems nationwide.
Compound Annual Growth Rate
6.1%
Value in USD Billion
2026-2035
*this image is indicative*
The market is steadily expanding as the demand for advanced and reliable treatment methods continues to rise across hospitals, clinics, and home care settings. Strong government initiatives, regulatory reforms, and rapid improvements in healthcare infrastructure are creating a favorable environment for the wider adoption of infusion-based treatments. Increasing cases of chronic and critical illnesses further support this demand, pushing providers to invest in safer and more accurate solutions such as infusion therapy systems. Backed by ongoing innovations, strategic initiatives, and growing patient needs, the market is set to witness consistent and long-term growth.
Government-Led Safety Improvements Propelling the Market Value
Growing emphasis on safer and more reliable treatment practices is likely to act as a strong growth driver in the market, as hospitals work to strengthen care standards and enhance patient protection. For instance, in October 2024, a report published by the National Institutes of Health (NIH) revealed that a structured safety bundle had a significant impact in reducing hospital-acquired infections in pediatric intensive care units. Such proven improvements encourage healthcare providers to adopt evidence-based safety frameworks that reduce risks and improve day-to-day clinical performance. This example demonstrates how similar safety-focused strategies in Mexico can elevate clinical outcomes, build greater trust in infusion procedures, and support the broader adoption of infusion therapies nationwide.
Rising Regulatory Reform Bolstering Growth in the Mexico Infusion Therapy Market
Accelerated regulatory approval processes have the potential to significantly boost the market by enabling faster introduction of advanced infusion equipment and supplies. For example, in July 2025, according to a report by the Regulatory Affairs Professionals Society (RAPS), Mexico formally adopted a “regulatory reliance” strategy that streamlines the approval of medical devices and health products, allowing regulators to rely on previously established authorizations from recognized agencies abroad. This move can lower barriers for import or launch of modern infusion pumps and IV consumables, encourage suppliers to enter the market sooner, and ultimately expand patient access to high quality infusion therapy across hospitals and clinics nationwide.
The market is witnessing several emerging trends, including rapid expansion of healthcare facilities, rising adoption of modern infusion technologies, and increasing focus on improving nationwide access to high-quality infusion services.
Rising Healthcare Infrastructure to Boost the Mexico Infusion Therapy Market Demand
A surge in Mexico’s public health infrastructure development is creating fertile ground for infusion therapy growth. For instance, in August 2025, the federal government announced that it would open 31 new hospitals and 12 clinics by the end of the year, backed by an MXN 21 billion investment to strengthen nationwide healthcare access. This expansion will increase hospital capacity and broaden geographic reach, meaning more facilities will be equipped and ready to offer infusion services such as IV therapy and parenteral nutrition, ultimately boosting overall demand for infusion therapy across Mexico.
Hospitals and Clinics Expected to Dominate the Market Share by End User
Hospitals and clinics are anticipated to lead the end-user segment as they handle the highest volume of complex treatments, emergency cases, and chronic disease management that rely heavily on infusion therapies. Their advanced infrastructure, trained staff, and wider access to specialized care allow faster adoption of new technologies, including infusion management systems, which enhance treatment accuracy and patient safety. This dominance strengthens overall market growth by driving consistent demand and setting higher standards of care. Other key segments in the market include ambulatory surgical centers, home care settings, and others.
The key features of the market report comprise funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:
Founded in 1839 and headquartered in Melsungen, Germany, B. Braun SE has grown into one of the world’s largest healthcare and medical technology companies. The company plays a major role in the infusion therapy market by offering advanced infusion pumps, IV sets, catheters, and medication safety solutions. Its strong focus on reducing infusion errors and improving patient safety supports hospitals and clinics in delivering reliable treatments. B. Braun’s continuous innovation and wide product availability make it a key contributor to the global and regional infusion therapy landscape.
Established in 1949 and headquartered in Dublin, Ireland, Medtronic plc is a global leader in medical technology with a strong presence across chronic disease management. In the infusion therapy industry, the company contributes through smart infusion systems and targeted drug-delivery solutions that enhance treatment precision and patient comfort. Medtronic’s long-standing focus on developing safe, automated, and user-friendly infusion technologies supports healthcare facilities in improving therapy outcomes. Its global scale and continuous R&D investment make it an influential player in advancing infusion care worldwide
Founded in 1897 and based in Franklin Lakes, New Jersey, USA, BD is one of the most prominent medical technology companies globally. The company significantly contributes to infusion therapy through its extensive portfolio of IV catheters, infusion sets, safety needles, and drug-delivery systems. BD’s innovations focus on infection prevention, accurate dosing, and improved workflow efficiency for healthcare professionals. Its strong commitment to clinical safety and manufacturing excellence positions BD as a key driver of quality and reliability within the infusion therapy market.
Established in 1984 and headquartered in San Clemente, California, USA, ICU Medical specializes in developing safe, clinically advanced infusion therapy technologies. The company contributes to the industry through needle-free connectors, infusion pumps, IV solutions, and closed system transfer devices designed to reduce contamination risks and enhance medication accuracy. ICU Medical’s solutions support hospitals in improving safety standards and simplifying infusion workflows. Its dedication to sterile, secure, and efficient drug delivery makes it an essential provider within the market.Top of FormBottom of Form
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players include Baxter AG, Terumo Medical Corporation, Fresenius Kabi, and Cardinal Health.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Indication
Market Breakup by Therapy Type
Market Breakup by End User
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Indication |
|
| Breakup by Therapy Type |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share